THE EFFECT OF PSIDIUM GUAJAVA LEAVES EXTRACTS AND THEIR EFFECTIVE COMPOUND AGAINST LEISHMANIA INFANTUM
Downloads
Objective: This study aims to evaluate the anti-leishmanial activity of aqueous and alcoholic extracts of Psidium guajava L. against Leishmania infantum. Additionally, it involves screening the phenolic and flavonoid compounds in the extracts using High-Performance Liquid Chromatography (HPLC). Methods: Standardized methods were employed to prepare aqueous and alcoholic extracts of Psidium guajava L. In vitro assays tested the inhibitory effect of these extracts on the growth of Leishmania infantum promastigotes, with the IC50 values determined. HPLC analysis identified flavonoids and phenolic compounds in the alcoholic extract. Data analysis explored the correlation between compound concentration and anti-leishmanial activity. Results: : The aqueous and alcoholic extracts exhibited significant inhibitory effects on Leishmania infantum promastigote growth. The IC50 value for the aqueous extract was 0.25 mg/mL, while the alcoholic extract showed a slightly higher potency with an IC50 of 0.23 mg/mL. HPLC analysis confirmed the presence of phenolic and flavonoid compounds in the alcoholic extract, which are likely responsible for the observed anti-leishmanial activity. Novelty: This study demonstrates the anti-leishmanial potential of Psidium guajava L., highlighting its aqueous and alcoholic extracts as promising candidates for further investigation. The identification of specific phenolic and flavonoid compounds provides insights into the bioactive components contributing to the inhibitory effects.
M. S. Abdullah and A. Q. Alqaisi, "Evaluating the in vitro anti-Leishmanial activity of essential oil extracted from Cymbopogon Citratus against Leishmania Donovani," Iraqi Journal of Science, vol. 63, no. 4, pp. 1453–1463, Apr. 2022.
J. Saki, E. Biranvand, and R. Arjmand, "The in vitro anti-Leishmania Effect of Zingiber officinale Extract on Promastigotes and Amastigotes of Leishmania major and Leishmania tropica," In Vitro, vol. 46, no. 2, pp. 91–96, Jun. 2022.
G. A. Gutiérrez-Rebolledo, S. Drier-Jonas, and M. A. Jiménez-Arellanes, "Natural compounds and extracts from Mexican medicinal plants with anti-leishmaniasis activity: An update," Asian Pacific Journal of Tropical Medicine, vol. 10, no. 12, pp. 1105–1110, Dec. 2017.
R. Mansour et al., "The effect of Vitis vinifera L. leaves extract on Leishmania infantum," Iranian Journal of Pharmaceutical Research: IJPR, vol. 12, no. 3, pp. 349–354, 2013.
C. K. Glidden et al., "Phylogenetic and biogeographical traits predict unrecognized hosts of zoonotic leishmaniasis," PLOS Neglected Tropical Diseases, vol. 17, no. 5, p. e00107, May 2023.
E. Berriatua et al., "Leishmaniases in the European Union and neighboring countries," Emerging Infectious Diseases, vol. 27, no. 6, pp. 1723–1730, Jun. 2021.
M. Y. Ali, "A study of the prevalence of leishmaniasis in Kirkuk Governorate and evaluation of some immunological and biochemical indicators in leishmaniasis patients," Web of Agriculture: Journal of Agriculture and Biological Sciences, vol. 2, no. 5, pp. 122–134, May 2024.
H. F. Hassan, A. A. Khalaf, and N. A. Ahmed, "Epidemiological survey of cutaneous leishmaniasis in Al-Hawija District, Kirkuk Province, Iraq," HIV Nursing, vol. 23, no. 1, pp. 703–710, 2023.
A. A. Rahi, "Cutaneous leishmaniasis in Iraq: A clinicoepidemiological descriptive study," Scholars Journal of Applied Medical Sciences, vol. 1, no. 6, pp. 1021–1025, 2013.
H. F. Hassan and S. A. Taha, "The use of Cymbopogon citratus (lemongrass) extracts as antileishmanial activity," Biochemical & Cellular Archives, vol. 20, no. 2, pp. 2733–2736, Oct. 2020.
H. M. Taher, S. A. Mohammed, and A. R. Mahmood, "Epidemiological study of cutaneous leishmaniasis in Kirkuk Province, Iraq," Plant Archives, vol. 20, no. 2, pp. 2733–2736, 2020.
A. Dayakar et al., "In vitro and in vivo evaluation of anti-leishmanial and immunomodulatory activity of Neem leaf extract in Leishmania donovani infection," Experimental Parasitology, vol. 153, pp. 45–54, Jun. 2015.
H. Nigatu et al., "In vitro antileishmanial activity of some Ethiopian medicinal plants," Journal of Experimental Pharmacology, vol. 13, no. 1, pp. 15–22, Jan. 2021.
E. Ghaderian et al., "Anti-leishmanial effects of Eryngium planum and Ecbilium elaterium methanolic extract against Leishmania major," AMB Express, vol. 14, no. 1, p. 3, Jan. 2024.
S. Naseer et al., "The phytochemistry and medicinal value of Psidium guajava (guava)," Clinical Phytoscience, vol. 4, no. 1, pp. 1–8, Dec. 2018.
G. A. Pereira et al., "Antimicrobial activity of Psidium guajava aqueous extract against sensitive and resistant bacterial strains," Microorganisms, vol. 11, no. 7, p. 1784, Jul. 2023.
M. E. El-Sesy and B. N. Mahran, "The antibacterial and coagulant activity of Psidium guajava leaves extracts in purification of wastewater," Biosciences Biotechnology Research Asia, vol. 17, no. 1, pp. 191–203, Mar. 2020.
A. O. Sule, A. O. Olalemi, and A. O. Ogundare, "Efficacy of leaf extracts of Psidium guajava (L.) on enteric bacterial isolates from faecally impacted groundwater," Water Practice & Technology, vol. 17, no. 1, pp. 167–174, Jan. 2022.
N. S. Sampath Kumar et al., "Extraction of bioactive compounds from Psidium guajava leaves and its utilization in preparation of jellies," AMB Express, vol. 11, pp. 1–9, Dec. 2021.
H. Zhang et al., "Progress in antileishmanial drugs: Mechanisms, challenges, and prospects," PLOS Neglected Tropical Diseases, vol. 19, no. 1, p. e0012735, Jan. 2025.
C. A. Antwi et al., "In vitro activity and mode of action of phenolic compounds on Leishmania donovani," PLOS Neglected Tropical Diseases, vol. 13, no. 2, p. e0007206, Feb. 2019.
M. G. Correa and J. S. Couto, "Anticancer properties of Psidium guajava—A mini-review," Asian Pacific Journal of Cancer Prevention, vol. 17, no. 9, pp. 4199–4204, Sep. 2016.
K. Iqbal et al., "Luteoline as a potent anti-leishmanial agent against intracellular Leishmania tropica parasite," Journal of Pharmaceutical Research, vol. 16, no. 2, pp. 337–342, 2017.
Copyright (c) 2024 Sahar A. Taha

This work is licensed under a Creative Commons Attribution 4.0 International License.














